Immunoblotting revealed a loss of FLT3 protein levels at a 5 nM concentration, while a cellular assay demonstrated cytotoxicity with an IC50 of 0.6 nM following 24‐h and 72‐h treatments of MV4‐11 AML cells, respectively. Here, FLT3 is linked to acute myeloid leukemia.